XORTX Therapeutics (XRTX) Dividends Paid - Common (2021 - 2026)
XORTX Therapeutics (XRTX) posted Dividends Paid - Common of $250275.0 for Q1 2026, up 91.87% on a QoQ basis from $130438.0 in Q3 2025, and down 86.79% year-over-year from $1.9 million in Q1 2025.
XORTX Therapeutics (XRTX) Dividends Paid - Common (2021 - 2026) Analysis & Trends
XORTX Therapeutics' Dividends Paid - Common history runs 6 years deep, the most recent figure standing at $250275.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 250,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,275.00 |
| Mar 31, 2026 | 250,275.00 |
| Sep 30, 2025 | 130,438.00 |
| Sep 30, 2025 | 130,438.00 |
| Jun 30, 2025 | -831,761.00 |
| Jun 30, 2025 | -831,761.00 |
| Mar 31, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Sep 30, 2024 | -777,725.00 |
| Sep 30, 2024 | -777,725.00 |
| Jun 30, 2024 | -756,968.00 |
| Jun 30, 2024 | -756,968.00 |
| Mar 31, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Mar 31, 2023 | 7.91 Mn |
| Mar 31, 2023 | 7.91 Mn |